Monday, December 05, 2005


Hep C Virus - Ciphergen and University of Texas Medical Branch at Galveston Sign Collaboration Agreement in Liver Disease


Ciphergen and University of Texas Medical Branch at Galveston Sign Collaboration Agreement in Liver Disease
PR Newswire - Professor of Internal Medicine atUTMB, have been studying how Hepatitis C infection can damage or destroy theliver

Peregrine Pharmaceuticals Names Leading Viral Experts to Its Scientific Resource Board
PR Newswire - Phase I clinical trial forthe treatment of chronic hepatitis C infection (HCV) and is being studiedpreclinically for use